quantisnow
FeedTopReportsPricing
⌘K
Live feed
22:35:00·2036d
PRRelease
Akcea Therapeutics, Inc. logo
Immunomedics, Inc. logo

SHAREHOLDER ALERT: WeissLaw LLP Reminds AKCA, IMMU, and MXIM Shareholders About Its Ongoing Investigations

AKCA· Akcea Therapeutics, Inc.IMMU· Immunomedics, Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • AKCA
    Akcea Therapeutics, Inc.
    Health Care
  • IMMU
    Immunomedics, Inc.
    Health Care

Related

  • FDA514d
    FDA Approval for TRODELVY issued to IMMUNOMEDICS INC
  • PR668d
    Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors
  • PR738d
    NorthStar Appoints Peter Pfreundschuh to Board of Managers
  • FDA1175d
    FDA Approval for TRODELVY issued to IMMUNOMEDICS INC
  • FDA1417d
    FDA Approval for TRODELVY issued to IMMUNOMEDICS INC
  • FDA1835d
    FDA Approval for TRODELVY issued to IMMUNOMEDICS INC
  • FDA1841d
    FDA Approval for TRODELVY issued to IMMUNOMEDICS INC
  • FDA1841d
    FDA Approval for TRODELVY issued to IMMUNOMEDICS INC
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022